Sanofi agrees to buy 150 million syringes a year from Unilife; Flexible drug patch conforms to skin;

> Unilife signed a long-term contract to supply prefilled syringes to Sanofi ($SNY), which plans to use them with its blood thinner Lovenox. The French company agreed to buy 150 million syringes a year, and Unilife expects to get between $5 million and $15 million in milestone payments out of the deal, which can be extended through 2024. Story

> Researchers at Virginia Tech and Wake Forest University have developed a flexible drug patch that conforms to the skin. More

> Synta rolled out its Hsp90-inhibitor drug conjugate platform, which helps deliver anticancer drugs directly to tumors. Release

> Mylan ($MYL) is expanding its U.S. transdermal patch facility, investing more than $600 million to double its capacity in St. Albans, VT. Article

> Plandai Biotechnology began clinical trials for its phytofare topical product based on nano-entrapment technology. Release

> NuPathe won a continuation of its patent for an iontophoretic patch with a two-stage sequence to deliver sumatripan through the skin. Its lead product, Zecuity, is approved by the FDA for migraines. Release

> A Johns Hopkins study showed similar effectiveness between two drug delivery systems for chronic obstructive pulmonary disease (COPD)--the Respimat inhaler and the HandiHaler, both from Boehringer Ingelheim. Report